(Q37998544)

26 August 2017

title

Blood biomarkers in stroke: research and clinical practice (English)

1 reference

26 August 2017

0 references

William Whiteley

1

0 references

Glen C. Jickling

object named as

Glen C Jickling

series ordinal

3

0 references

author name string

Yingfang Tian

series ordinal

2

1 reference

26 August 2017

publication date

30 March 2012

1 reference

International Journal of Stroke

26 August 2017

published in

1 reference

26 August 2017

volume

7

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

435-439

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Blood biomarkers in the diagnosis of ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Cancer biomarkers: can we turn recent failures into success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Utilizing human blood plasma for proteomic biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Gene expression profiling of blood for the prediction of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Signatures of cardioembolic and large‐vessel ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

C-reactive protein in ischemic stroke: an independent prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Biomarkers of cardiovascular disease: molecular basis and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Blood markers for the prognosis of ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Effects of CYP2C19 genotype on outcomes of clopidogrel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00784.X

10.1111/J.1747-4949.2012.00784.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference